GENNEX LABORATORIES
|
The Current P/S Ratio of GENNEX LABORATORIES is 1.21.
| Share Price | ₹9.1 | Oct 28,2026 |
| Market Cap | ₹221.0 Cr | |
| Sales-TTM | ₹183.1 Cr | TTM-Consolidated Results |
| Price/Sales | 1.21x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GENNEX LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹221.0 Cr] as on Oct 28,2026
(/) Sales [ ₹183.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.21x ]
Thus, for GENNEX LABORATORIES , the investors are currently willing to pay '1.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GENNEX LABORATORIES !
The chart below summarizes the trend in P/S Ratio of GENNEX LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of GENNEX LABORATORIES
PS Ratio Performance Analysis for GENNEX LABORATORIES
- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 2.04x.
- GENNEX LABORATORIES 's operated at median p/e ratio of 1.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 4.14x.
- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2026 of 1x.
How does GENNEX LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GENNEX LABORATORIES | 183.1 | 1.21 | 221.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.04 | 421,803.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.60 | 253,833.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 9.97 | 173,461.0 |
| CIPLA LTD | 28,138.9 | 3.90 | 109,870.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.37 | 111,463.0 |
| MANKIND PHARMA LTD | 15,378.6 | 6.67 | 102,584.0 |
| LUPIN LTD | 29,966.6 | 3.01 | 90,132.5 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.09 | 116,907.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.70 | 94,367.7 |
| LAURUS LABS LTD | 7,269.6 | 16.24 | 118,056.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GENNEX LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.21x |
| Max industry PS | 22.60x |
| Median industry PS | 4.09x |
| Average industry PS | 7.35x |
You may also like the below Video Courses